XYREM
XYREM
Approved
DIN Number
02268272
Drug Class
Human
Market Date
Aug 3, 2007
Company
HC
JAZZ PHARMACEUTICALS IRELAND LIMITED
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02268272
AIG Number0151061001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule G (CDSA I)
A
ATC Code
N07XX04 HYDROXYBUTYRIC ACID
Product Specifications
Dosage FormSolution
Route of AdministrationOral
AHFS Classification28:92.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
SODIUM OXYBATEActive
Strength: 500 MG / ML
Monograph: SODIUM OXYBATE